Susquehanna International Group (Ireland)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$217K Buy
+7,513
New +$219K 0.05% 98
2022
Q4
Sell
-6,900
Closed -$302K 64
2022
Q3
$302K Hold
6,900
0.1% 48
2022
Q2
$362K Sell
6,900
-957
-12% -$48.8K 0.09% 56
2022
Q1
$407K Buy
+7,857
New +$408K 0.14% 47
2021
Q2
Sell
-6,193
Closed -$224K 109
2021
Q1
$224K Buy
+6,193
New +$220K 0.09% 91

Other funds holding PFE

Susquehanna International Group (Ireland)'s PFE Position: Q3 2024 in Review

Susquehanna International Group (Ireland) opened a new position in Pfizer (PFE) in Q3 2024: 7,513 shares worth $217K. The stake represents 0.05% of the portfolio and ranks #98 among its holdings. This is a return to the name: Susquehanna International Group (Ireland) previously reported a position in PFE as recently as Q3 2022.

Susquehanna International Group (Ireland) first reported a position in PFE in Q1 2021 and has held it in 5 quarters since. The position peaked at $407K in Q1 2022. 2,915 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Susquehanna International Group (Ireland) held 7,513 shares of Pfizer worth $217K as of Q3 2024.
  • Pfizer was a new Susquehanna International Group (Ireland) position in Q3 2024.
  • Pfizer made up 0.05% of Susquehanna International Group (Ireland)'s portfolio in Q3 2024, its #98 holding.
  • Susquehanna International Group (Ireland) first reported a position in Pfizer in Q1 2021 and has held it in 5 quarters since.
  • Susquehanna International Group (Ireland)'s Pfizer position peaked at $407K in Q1 2022.
  • 2,915 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Susquehanna International Group (Ireland)'s 13F filing for Q3 2024, filed 14 Nov 2024.